How can Next Generation Proteomics improve translational decisions?
Why attend
Join Biotest Facility and Olink Proteomics at Symbion Østerbro for a morning focused on
biomarker strategies in preclinical pharmacology and clinical research. The event brings
together researchers and industry professionals to discuss translational insights and practical application on how to:
- Identify clinically relevant biomarkers earlier and with higher precision
- Stratify patients based on underlying biology—not just phenotype
- Understand disease mechanisms and treatment response at scale
Program
| 10:00 | From sample to insight: Plasma proteomics in clinical research. Carsten Nielsen, Field Application Scientist – Olink Proteomics part of Thermo Fisher Scientific |
| 10:30 | Case Study in Clinical Immuno–Oncology. Sidsel C. Lindgaard, BRIDGE fellow Herlev Hospital & KU |
| 10:50 | Networking with Coffee and Cake |
| 10:20 | Biotest Facility – Strenghtening in vivo pharmacology w. molecular markers. Michael Solgaard, Business Developer – Biotest facility |
| 11:50 | Wrap up |
| 12:00 | End of Seminar |
Date: Tuesday, 9 June 2026
Time: 10:00–12:00
Venue: Symbion Østerbro, Fruebjergvej 3, 2100 København, Denmark